gemcitabine has been researched along with iopamidol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cha, SW; Chung, JB; Kim, KW; Kim, MJ; Klotz, E; Lim, JS; Park, MS; Park, SW; Seong, J; Song, SY | 1 |
3 other study(ies) available for gemcitabine and iopamidol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Volume; Combined Modality Therapy; Contrast Media; Deoxycytidine; Extracellular Fluid; Female; Fluid Shifts; Follow-Up Studies; Gemcitabine; Humans; Iopamidol; Male; Middle Aged; Pancreatic Neoplasms; Plasma Volume; Portography; Prospective Studies; Radiotherapy Dosage; ROC Curve; Tomography, Spiral Computed; Treatment Outcome | 2009 |